Matthew Leonard
Directeur/Membre du Conseil chez ANI PHARMACEUTICALS, INC.
Fortune : 763 714 $ au 30/06/2024
Profil
Matthew J.
Leonard is an Independent Director at ANI Pharmaceuticals, Inc. since 2023.
Previously, he served as the Executive VP & President-North America at Covetrus, Inc. from 2019 to 2020.
He completed his undergraduate degree at the University of Rhode Island Graduate School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2024 | 11 993 ( 0,06% ) | 763 714 $ | 30/06/2024 |
Postes actifs de Matthew Leonard
| Sociétés | Poste | Début |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 21/08/2023 |
Anciens postes connus de Matthew Leonard
| Sociétés | Poste | Fin |
|---|---|---|
| COVETRUS, INC. | Corporate Officer/Principal | 07/01/2020 |
Formation de Matthew Leonard
| University of Rhode Island Graduate School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Covetrus, Inc.
 Covetrus, Inc. Packaged SoftwareTechnology Services Covetrus, Inc. engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships and successful financial outcomes for veterinary professionals. The firm geographically operates through the segments: North America, Europe and Asia Pacific (APAC) & Emerging Markets. The company was founded by Benjamin J. Shaw in April 2018 and is headquartered in Portland, ME. | Technology Services |
